0001213900-21-007499.txt : 20210208 0001213900-21-007499.hdr.sgml : 20210208 20210208173047 ACCESSION NUMBER: 0001213900-21-007499 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210203 FILED AS OF DATE: 20210208 DATE AS OF CHANGE: 20210208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIDRON NADAV CENTRAL INDEX KEY: 0001351779 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35813 FILM NUMBER: 21602717 MAIL ADDRESS: STREET 1: 142 W. 57TH ST. CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001176309 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980376008 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-844-1164 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Integrated Security Technologies, Inc. DATE OF NAME CHANGE: 20040614 FORMER COMPANY: FORMER CONFORMED NAME: IGUANA VENTURES LTD DATE OF NAME CHANGE: 20020625 4 1 ownership.xml X0306 4 2021-02-03 0 0001176309 ORAMED PHARMACEUTICALS INC. ORMP 0001351779 KIDRON NADAV 1185 AVENUE OF THE AMERICAS NEW YORK NY 10036 1 1 1 0 President and CEO Stock Option (right to buy) 10.40 2021-02-03 4 A 0 150000 0 A 2031-02-03 Common Stock 150000 150000 D The Stock Option will vest in 4 equal installments as follows: 37,500 shall vest on each of December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. /s/ Nadav Kidron 2021-02-08